Isotonische Kochsalzlösung 0,9% Bernburg (Sodium Chloride)

The solution provides sodium (Na⁺) and chloride (Cl⁻) ions that increase the osmolarity of the extracellular compartment. This draws water into the vascular space, expanding plasma volume and correcting hyponatremia while maintaining acid‑base balance. Its isotonic concentration matches plasma, limiting cellular shifts.

The prescribed dose is individualized by the treating clinician based on the patient’s weight, clinical condition, and the extent of fluid loss. The prescriber calculates the required volume to achieve the desired plasma expansion and monitors the response during therapy.

Safety data for Isotonische Kochsalzlösung 0,9% in pregnancy and lactation are limited. It may be used when clearly needed, but the prescriber should evaluate the risk‑benefit ratio for each patient and consider alternative therapies if appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Isotonische Kochsalzlösung 0,9% contains only sodium and chloride, making it a pure saline solution, whereas Ringer's lactate also provides potassium, calcium and lactate. Saline is preferred when a simple isotonic fluid is needed, while Ringer's lactate may be chosen for patients requiring additional electrolytes and a more physiologic buffer.

Store the product at ambient temperature, below 25 °C, in its original sealed container. Protect it from direct sunlight, moisture and extreme temperatures. Inspect the vial for particulate matter or discoloration before use and discard if the seal is compromised.

The solution is administered intravenously, typically through a peripheral or central venous catheter. The prescriber determines the infusion rate and total volume based on the clinical scenario. Infusion sets should be primed to remove air, and the line should be monitored for signs of infiltration or adverse reactions.

Serious risks include severe hypernatremia, fluid overload leading to pulmonary edema, and rare anaphylactic reactions. Patients with compromised cardiac or renal function are particularly vulnerable, so close monitoring of fluid balance, vital signs and serum electrolytes is essential during therapy.

The solution should be avoided in patients with known hypersensitivity to sodium chloride, uncontrolled heart failure, severe renal impairment, or conditions where excessive fluid administration could worsen edema. Contraindications are determined by the prescriber based on the individual’s medical history.